Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 4
1(25.0%)
4Total
N/A(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT07065799Not ApplicableRecruiting

Respiratory Strategies in COPD Patients With Persistent Hypercapnia Following Exacerbation

Role: collaborator

NCT06256406Not ApplicableRecruiting

Effects of Confortable Environment, Kangaroo Care and Music Therapy in Newborns in Neonatal Intensive Care Unit

Role: lead

NCT04853836Phase 4Completed

Olfactory Disfunction and Co-ultraPEALut

Role: collaborator

NCT05189613Not ApplicableUnknown

Mepolizumab Effectiveness in Severe Eosinophilic Asthma and Bronchiectasis

Role: lead

NCT03489603Completed

Clinical and Economic Outcomes of High Sensitivity Troponin for no ST Elevation Myocardial Infarction in Patients With Chest Pain in Emergency Departments in Italy-An Observational Study

Role: collaborator

NCT03339063Unknown

The Italian REgistry of Pulmonary Non-tuberculous mycobactEria

Role: collaborator

NCT01142830Completed

Incidence of Pain After Craniotomy in Children

Role: collaborator

All 7 trials loaded